0440 An Internet of Things Cognitive Behavioral Therapy-based Device Reduces Insomnia Severity and Increases Sleep Time
Jean Kim,Daniel Gartenberg,Eben Bitonte,Clete Kushida
DOI: https://doi.org/10.1093/sleep/zsae067.0440
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction An estimated 34-million U.S. adults suffer from chronic insomnia. The first-line treatment for this disease is Cognitive Behavioral Therapy for Insomnia (CBT-I). However, poor access, high cost, and low adherence prevent its widespread use. Full Sleep is a novel Internet of Things (IoT) device that includes an intelligence-sensing radar to passively track sleep patterns and deliver in the moment behavioral prompting to promote adherence to CBT-I directives. Methods The effect of the IoT device was examined on participants with moderate to severe insomnia symptoms (n = 65). Participants were recruited through a website and consented to a 6-8 week program. The IoT device was hypothesized to improve the Insomnia Severity Index (ISI) (primary outcome), evaluated at baseline and post-treatment. The IoT device was also hypothesized to improve consensus sleep diary metrics. Exploratory hypotheses included increasing total sleep time and reducing depression and anxiety on survey assessments. Results A within-groups paired-comparison t-test showed significant improvements in the ISI from baseline 19.3 (SD = 2.5) to post-treatment 7.4 (SD = 4.6), t(43) = 16.89, p < .001, d = 2.5, a 62% decrease. A clinically significant change is 6-points, demonstrating a dramatic improvement, and a larger effect than reported by digital therapeutics like Somryst, which found a 45% decrease in the ISI. There was also evidence of a causal relationship between improvements in the ISI and the use of the IoT device, where the more that participants engaged with the feature that promoted getting out of bed during restless nights, the greater the improvement in the ISI score r(42) = .37, p < .05. Importantly, the intervention also increased total sleep time, from 6.3 hours (SD = 1.4) to 6.8 hours (SD = 1.4), t(51) = 4.14, p < .05, and sleep efficiency from 73.6% (SD = 13.7%) to 88.6% (SD = 8.9%), t(51) = 9.9, p < .05. Participants had a reduction in dysfunctional beliefs about sleep, depressive symptoms, and anxious symptoms (ps < .05). Conclusion These results support that innovative technologies that work alongside CBT-I directives can reduce insomnia severity and increase total sleep time. Support (if any) This research was supported by Koko Home Inc.
neurosciences,clinical neurology